How do you invest your money over the long-term? If you’ve read much of our work, you’ve probably noticed we embrace evidence-based investing. But what does that mean?
What is Evidence-Based Investing?
Evidence-based investors build and manage their portfolio based on what is expected to enhance future returns and/or dampen related risk exposures, according to the most robust evidence available. This also means sticking with your long-view, evidence-based strategy once it’s in place, despite the market’s uncertainties and your own self-doubts you’ll encounter along the way.
Evidence-Based Investing, Applied
Do you hope…
1. Investors can come out ahead by finding mispriced stocks, bonds, and other trading opportunities; and/or by dodging in and out of rising and falling markets?
Or do you accept…
2. The market’s rapid-fire trading creates relatively efficient pricing that is too random to consistently predict? (Check out our 20-minute podcast on the Economic Mirage.)
There is an overwhelming body of empirical evidence suggesting investors should skip the first approach and act on the second assumption. This has been the case since at least 1952, when Harry Markowitz published Portfolio Selection in The Journal of Finance. In their book, In Pursuit of the Perfect Portfolio, professors Andrew Lo and Stephen Foerster describe:
“While it’s commonplace now to think of creating a diversified portfolio rather than investing in a collection of securities that each on their own look promising, that wasn’t always the case. It was Harry Markowitz who provided a theory and a process to the notion of diversification. He helped to create the industry of portfolio management.”
Markowitz’s work became known as Modern Portfolio Theory (MPT) and ultimately earned him a Nobel Prize. Academics and practitioners have been building on it ever since. His initial work and others’ subsequent findings strongly support ignoring all the near-term noise and taking a long-view approach. This involves building a unified investment portfolio and focusing on more manageable details, such as:
- Tilting toward or away from entire asset classes to tailor your risks and expected returns
- Minimizing avoidable risks by diversifying globally
- Reducing unnecessary costs
- Controlling your own damaging behavioral biases
How Do You Decide Which Evidence to Heed?
So far, so good. Then again, at first blush, nearly every investment recommendation may seem “evidence-based.” After all, few forecasters would peer into actual crystal balls to make their predictions. And no market guru would admit their stock-picking track record has been no better than a dart-throwing monkey’s (even though that’s usually the case).
Instead, stock-picking and market-timing enthusiasts tend to argue their cases by turning to articulate analyses, smart charts, and convincing corporate briefs. They use these props to explain the late-breaking news and recommend what you should supposedly be doing about it.
There’s nothing wrong with facts and figures. The critical difference is how we apply them as evidence-based investors. As financial author Larry Swedroe describes it:
“In investing, there is a major difference between information and knowledge. Information is a fact, data or an opinion held by someone. Knowledge, on the other hand, is information that is of value.”
No matter how compelling a call to action may be, we discourage frequent reaction to the never-ending onslaught of information. As Warren Buffett reminds us, “The stock market is designed to transfer money from the active to the patient.”
First, we must determine:
- Which information might add substantive value to our decisions by refuting or adding to the existing evidence?
- Which is just more of the same old noise, already factored into your evidence-based investment strategy?
The Evidence-Based Silver Bullet: Academic Rigor
Because there is a lot more noise than there is valuable knowledge, the basic recipe for evidence-based investing begins and ends with academic rigor. It should always be a key ingredient in separating likely fact from probable fiction:
- It requires robust data sets that are large enough, representative enough, and free from other common data analysis flaws.
- Authors should be impartial, lacking incentives to “torture” the data to make a point.
- Other studies should be able to reproduce the same findings under different scenarios, suggesting the results are more likely to persist upon discovery.
- The data, methodology, and results should be published in reputable, peer-reviewed forums where informed colleagues can comment on the findings.
- Enough time must pass to make all of the above possible.
After that, we also must be able to apply the results in the real world. In other words, even if a theoretical strategy is expected to enhance your returns, it must do so after considering all practical costs and portfolio-wide tradeoffs involved. For example, sometimes one source of expected returns may offset another, even bigger source. Sometimes, we can combine them for even stronger results. Other times, it’s best to favor one over the other.
Evidence-Based Investment Factors
So, which factors appear to best explain different outcomes among different portfolios? In what combinations are these factors expected to create the strongest, risk-adjusted portfolios? What explains each factor’s return-generating powers, and can we expect those powers to persist? To be considered a dimension of expected return, a “premium” must be: sensible, persistent, pervasive, robust, and cost-effective to capture.
Based on the academic answers to these practical questions, we typically mix and match the following factors in our evidence-based portfolios, varying specific exposures based on each investor’s personal goals and risk tolerances:
Check out our previous blog post about Evidence-Based Investing vs. Index Investing.
What’s in an Evidence-Based Name?
Last but not least, it’s worth mentioning, others may refer to the same or similar approaches by various names, such as factor-based, asset-based, quantitative investing, or science-based investing.
These terms are relatively interchangeable, but there’s a reason we’ve chosen evidence-based as our preferred expression.
Heeding sound reason and rational evidence is at the root of what we do. Therefore, we believe it should be at the root of what we call it.
There are notable similarities between evidence-based investing and evidence-based medicine.
Global healthcare leader Johns Hopkins Medicine defines evidence-based medicine this way,
“Evidence-based medicine is the integration of best research evidence with clinical expertise and patient values. Evidence-based medicine is an interdisciplinary approach which uses techniques from science, engineering, biostatistics and epidemiology, such as meta-analysis, decision analysis, risk-benefit analysis, and randomized controlled trials to deliver the right care at the right time to the right patient.”
What would your best evidence-based investment portfolio look like? It depends on your personal financial goals; as well as your willingness, ability, and need to take on investment risks in pursuit of those goals.
That’s where we come in, to structure the right mix for you informed by your values and goals, and help you navigate through the ever-distracting informational overload.
Schedule a call today with one of our advisors.
This article was originally written by Wendy Cook and used with her permission. This blog is for informational purposes only. It should not be retransmitted in any form without the express written consent of Delap Wealth Advisory, LLC, an investment advisor registered with the United States Securities & Exchange Commission. The contents of this communication should not be construed as investment advice intended for any particular individual or group of individuals. All information, statements, comments, and opinions contained in this blog regarding the securities markets or other financial matters is obtained (or based upon information obtained) from sources which we believe to be reliable and accurate. However, we do not warrant or guarantee the timeliness, completeness, or accuracy of any information or opinions presented herein. Any historical price or value is as of the date indicated. Information is provided as of the date of this material only and is subject to change without notice.
Investing in securities involves the risk of loss, including the risk of loss of principal, which clients should be prepared to bear. No assurance is given that the investment objectives of any investment described in this communication will be achieved. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The information contained in this blog is not intended as tax or legal advice, and Delap Wealth Advisory, LLC, does not provide any tax or legal advice to clients. You should consult with our firm or other independent financial, legal, and/or tax advisors before considering any investment or participation in any investment program.